|
ZFR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.825300E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.836500E-03 |
| Normal-vs-Stage2 |
2.338000E-02 |
| Normal-vs-Stage3 |
6.10079999999735E-05 |
| Normal-vs-Stage4 |
5.55069999963465E-07 |
| Stage1-vs-Stage2 |
8.819400E-01 |
| Stage1-vs-Stage3 |
5.736300E-02 |
| Stage1-vs-Stage4 |
1.122840E-03 |
| Stage2-vs-Stage3 |
2.480800E-01 |
| Stage2-vs-Stage4 |
4.021900E-02 |
| Stage3-vs-Stage4 |
1.891240E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.845600E-04 |
| Normal-vs-AfricanAmerican |
1.346760E-01 |
| Normal-vs-Asian |
8.802600E-03 |
| Caucasian-vs-AfricanAmerican |
4.053000E-01 |
| Caucasian-vs-Asian |
7.114400E-01 |
| AfricanAmerican-vs-Asian |
6.266200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.799180E-04 |
| Normal-vs-Female |
1.422080E-03 |
| Male-vs-Female |
4.372600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.440430E-02 |
| Normal-vs-Age(41-60Yrs) |
5.034100E-04 |
| Normal-vs-Age(61-80Yrs) |
3.65220000000388E-05 |
| Normal-vs-Age(81-100Yrs) |
1.913640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.241240E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.497800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.329200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.534600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.840800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.383800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.790900E-04 |
| Classical-VS-Follicular |
1.129590E-01 |
| Classical-VS-Other |
9.786000E-01 |
| Classical-VS-Normal |
8.663000E-03 |
| Tall-VS-Follicular |
4.242100E-02 |
| Tall-VS-Other |
2.383400E-01 |
| Tall-VS-Normal |
3.64419999998589E-06 |
| Follicular-VS-Other |
6.272000E-01 |
| Follicular-VS-Normal |
2.003600E-03 |
| Other-VS-Normal |
3.200000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.968000E-04 |
| Normal-vs-N1 |
3.75679999999878E-05 |
| N0-vs-N1 |
1.696830E-01 |
|
|
